Document Type

Article

Publication Date

1-1-2008

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in International Reviews of Immunology Volume 27, Issue 5, September 2008, Pages 351-374. The published version is available at . DOI: 10.1080/08830180802295740. Copyright © informaworld.

Abstract

The nuclear factor-kappa B family of transcription factors is intimately involved in the regulation of the inflammatory responses that play a fundamental role in the damage of articular tissues. Thus, many studies have examined the important contributions of components of the NF-kappaB signaling pathways to the pathogenesis of various rheumatic diseases and their pharmacologic modulation. Currently available therapeutic agents including nonsteroidal anti-inflammatory drugs, corticosteroids, nutraceuticals, and disease-modifying antirheumatic drugs, as well as novel specific small-molecule inhibitors have been employed. In addition, promising nucleic acid-based strategies have shown encouraging results. However, further research will be needed before NF-kappaB-aimed strategies become an effective therapy for inflammatory arthritis.

Share

COinS